---
schema_version: "secwatch.filing_event.v1"
accession: "0001638833-23-000093"
form_type: "8-K"
ticker: "SGRY"
cik: "0001638833"
company_name: "Surgery Partners, Inc."
filed_at: "2023-11-07T23:59:59+00:00"
generated_at: "2026-06-08T15:36:58.614523+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Surgery Partners Q3 revenue up 8.6% to $674M; raises FY Adjusted EBITDA guidance to $436-440M

## Summary
- Revenues $674.1M (+8.6% YoY); net loss improved to $4.9M from $25M.
- Adjusted EBITDA $105.5M (+9.7% YoY); margin improved to 15.7%.
- Same-facility revenues up 14.2% (days adjusted); case volume +2.9%, revenue per case +11.0%.
- Full-year 2023 Adjusted EBITDA guidance raised to $436-440M; revenue ~$2.75B.
- Free Cash Flow of $63.2M in Q3; cash and revolver availability $781M total.

## SEC filing metadata
- accession: 0001638833-23-000093
- form_type: 8-K
- ticker: SGRY
- cik: 0001638833
- company_name: Surgery Partners, Inc.
- filed_at: 2023-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000093/0001638833-23-000093-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000093/sgry-20231107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001638833-23-000093
- JSON: https://secwatch.observer/filing/0001638833-23-000093.json
- Plain text: https://secwatch.observer/filing/0001638833-23-000093.txt

## Key facts
- Earnings Releases
  Surgery Partners, Inc. reported 2023 results: revenue approximately $2.75 billion. Guidance raised.
  - Period: 2023
  - Revenue: approximately $2.75 billion
  - Guidance: raised
  - Result: guidance update
  source text: The Company raised projected 2023 Adjusted EBITDA to a range of $436 million to $440 million and anticipates revenue at approximately $2.75 billion.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000093/0001638833-23-000093-index.htm
- Earnings Releases
  Surgery Partners, Inc. reported year-to-date 2023 results: revenue $2,007.9 million, net income $10.9 million.
  - Period: year-to-date 2023
  - Revenue: $2,007.9 million
  - Net income: $10.9 million
  - Result: reported results
  source text: respectively, compared to $25.0 million and $96.2 million, respectively, for the same period last year. Year-to-Date 2023 Results Revenues year-to-date 2023 increased 9.6% to $2,007.9 million from $1,832.2 million for the 2022 period. Days adjusted same-facility revenues for year-to-date 2023 increased 10.6% from the same period last year, with an increase in revenue
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000093/0001638833-23-000093-index.htm
- Earnings Releases
  Surgery Partners, Inc. reported third quarter ended September 30, 2023 results: revenue $674.1 million, net income $4.9 million.
  - Period: third quarter ended September 30, 2023
  - Revenue: $674.1 million
  - Net income: $4.9 million
  - Result: reported results
  source text: Partners" or the "Company"), a leading operator of surgical facilities, today announced financial results for the third quarter ended September 30, 2023. • Revenues were $674.1 million representing 8.6% growth • Days Adjusted Same-facility revenues increased 14.2% • Net loss attributable to Surgery Partners was $4.9 million • Adjusted EBITDA was $105.5 million,
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000093/0001638833-23-000093-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.